| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP Of Research &Development
2 companies
Shih Alvin is an EVP Of Research &Development at Travere Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $7.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | ZVRA Zevra Therapeutics, Inc. | Director | Buy | 20,000 | $7.89 | $157,800.00 | New | +8.3% | - | |
| Sep 1, 2016 | TVTX Travere Therapeutics, Inc. | EVP Of Research &Development | Sell | 8,750 | $16.24 | $142,058.88 | -5.2% | - | - | |
| Jun 1, 2016 | TVTX Travere Therapeutics, Inc. | EVP Of Research &Development | Sell | 8,750 | $17.75 | $155,283.63 | -5.0% | - | - | |
| Mar 1, 2016 | TVTX Travere Therapeutics, Inc. | EVP Of Research &Development | Sell | 8,750 | $14.35 | $125,568.63 | -4.7% | - | - | |
| Dec 9, 2015 | TVTX Travere Therapeutics, Inc. | EVP Of Research &Development | Sell | 8,750 | $20.83 | $182,262.50 | -4.5% | - | - | |
| Oct 6, 2015 | TVTX Travere Therapeutics, Inc. | EVP Of Research &Development | Sell | 8,750 | $20.12 | $176,072.88 | -1.5% | - | - | |
| Jun 26, 2015 | TVTX Travere Therapeutics, Inc. | EVP Of Research &Development | Sell | 27,916 | $32.70 | $912,850.41 | -12.1% | - | - |